DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
Lenalidomide and dexamethasone ( DrugBank:
Lenalidomide
,
Dexamethasone
)
1 disease
告示番号
疾患名
(ページ内リンク)
臨床試験数
16
クロウ・深瀬症候群
2
16. クロウ・深瀬症候群
臨床試験数
:
13
/
薬物数
:
14
- (
DrugBank
:
7
) /
標的遺伝子数
:
4
-
標的パスウェイ数
:
75
10
50
100
ALL
diseases per page:
Showing 1 to 2 of 2 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
NCT01639898
(
ClinicalTrials.gov
)
July 2012
5/7/2012
POEMS Syndrome Treatment With Lenalidomide
Phase II Trial With Lenalidomide-Dexamethasone Combination in the Treatment of POEMS Syndrome.
POEMS Syndrome
Drug:
Lenalidomide and dexamethasone
University Hospital, Limoges
Ministry of Health, France;Celgene Corporation
Completed
18 Years
N/A
All
51
Phase 2
France
2
NCT00971685
(
ClinicalTrials.gov
)
July 2009
3/9/2009
The Treatment of Lenalidomide in Patients With POEMS Syndrome
Evaluation of Efficacy and Safety of Lenalidomide (Revlimid®) in Patients With POEMS Syndrome
POEMS Syndrome
Drug:
Lenalidomide and dexamethasone
Istituto Clinico Humanitas
NULL
Recruiting
18 Years
N/A
Both
16
Phase 2
Italy